HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The severe combined immunodeficient mouse as a model for Encephalitozoon cuniculi microsporidiosis.

Abstract
Microsporidia have been recently recognized as opportunistic pathogens in AIDS patients. In attempt to develop an animal model with features similar to the infections observed in the immunodeficient patients, the adult severe combined immunodeficient mice (SCID) were administered both intraperitoneally and perorally by 2 x 10(7) spores of the murine isolate of E. cuniculi. The experimental inoculation caused a severe, fatal disease characterized by the dissemination of microsporidia into the host tissues. The dominant route of E. cuniculi dissemination in the SCID mice was continual direct extension from the site of inoculation to adjacent tissues and organs, terminating in hematogenous spread of infection in the host. The different courses of microsporidiosis in SCID mice relative to the mode of inoculation (i.p. vs. p.o.) was observed. The survival time of i.p. infected SCID mice was 3 weeks--vs. 5 weeks in p.o. infected SCID mice. Experimental microsporidiosis in SCID mice should provide a useful model for studies in microsporidial pathogenesis, mechanisms of resistance, immunotherapy, and in evaluating potential antimicrosporidial agents.
AuthorsB Koudela, J Vítovec, Z Kucerová, O Ditrich, J Trávnícek
JournalFolia parasitologica (Folia Parasitol (Praha)) Vol. 40 Issue 4 Pg. 279-86 ( 1993) ISSN: 0015-5683 [Print] Czech Republic
PMID8013928 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Animals
  • Disease Models, Animal
  • Encephalitozoon (ultrastructure)
  • Encephalitozoonosis (parasitology)
  • Female
  • Male
  • Mice
  • Mice, SCID (parasitology)
  • Severe Combined Immunodeficiency (parasitology)
  • Spleen (parasitology)
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: